"BANCA FINNAT EURAMERICA S.P.A." E, IN FORMA ABBREVIATA "BANCA FINNAT S.P.A." O ANCHE "BANCA EURAMERICA S.P.A." financials
"BANCA FINNAT EURAMERICA S.P.A." E, IN FORMA ABBREVIATA "BANCA FINNAT S.P.A." O ANCHE "BANCA EURAMERICA S.P.A."
Country: IT Reporting currency: EUR Latest annual report: 2021-12-31
LEI:
815600835712F7BA2869 Financial statements
(EUR, as reported — unscaled; 96 line items across 2 annual periods)
| Line item | 2021 | 2020 |
|---|---|---|
| Income statement | ||
| Administrative expenses | €55.9M | €52.2M |
| Operating expenses | €53.9M | €51.1M |
| Employee benefits expense | €38.1M | €36.0M |
| Profit before tax | €12.1M | €11.6M |
| Income tax expense | €3.5M | €3.8M |
| Profit for the year | €8.6M | €7.8M |
| — attributable to owners | €6.1M | €5.1M |
| — attributable to NCI | €2.5M | €2.7M |
| Total comprehensive income | €11.4M | €9.8M |
| Cash flow statement | ||
| Cash generated from operations | €2.7M | €20.5M |
| Net cash from operating activities | €47.4M | €2.9M |
| Net cash from investing activities | -€248.0K | €113.0K |
| Purchase of PP&E (capex) | €125.0K | €101.0K |
| Purchase of intangibles | €124.0K | €119.0K |
| Net cash from financing activities | -€4.4M | €0 |
| Dividends paid | €4.4M | €0 |
| Net change in cash | €42.7M | €3.0M |
| Balance sheet | ||
| Total assets | €1.95B | €1.84B |
| Property, plant & equipment | €19.9M | €17.9M |
| Intangible assets & goodwill | €31.1M | €31.2M |
| Cash & equivalents | €115.4M | €72.7M |
| Total equity | €260.8M | €262.7M |
| — attributable to owners | €227.2M | €222.3M |
| Non-controlling interests | €33.6M | €40.4M |
| Deferred tax liabilities | €1.6M | €1.2M |
| Derived metrics | ||
| Free cash flow | €47.3M | €2.8M |
| Return on equity | 3.3% | 3.0% |
| Cash conversion ratio | 5.49× | 0.37× |
| Capex coverage | 379.22× | 28.34× |
| Other reported items | ||
| Adjustments For Decrease Increase In Financial Assets Held For Trading | -€1.7M | €51.0M |
| Adjustments For Decrease Increase In Other Assets | -€15.2M | €1.6M |
| Adjustments For Depreciation and Amortisation Expense and Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss | €3.7M | €3.7M |
| Adjustments For Income Tax Expense | -€3.5M | -€3.8M |
| Adjustments For Increase Decrease In Financial Liabilities Held For Trading | €2.0M | -€112.0K |
| Adjustments For Increase Decrease In Other Liabilities | €6.3M | -€1.8M |
| Adjustments For Provisions | -€1.8M | €1.8M |
| Cash Flows From Losing Control of Subsidiaries Or Other Businesses Classified As Investing Activities | €0 | €0 |
| Cash Flows Used In Obtaining Control of Subsidiaries Or Other Businesses Classified As Investing Activities | €0 | €0 |
| Comprehensive Income Attributable To Noncontrolling Interests | €2.6M | €2.7M |
| Comprehensive Income Attributable To Owners of Parent | €8.8M | €7.1M |
| Current Tax Assets | €74.0K | €809.0K |
| Current Tax Liabilities | €911.0K | €487.0K |
| Deferred Tax Assets | €9.9M | €9.5M |
| Deposits From Banks | €394.0K | €157.0K |
| Deposits From Customers | €1.65B | €1.55B |
| Dividends Received From Investments Accounted For Using Equity Method Classified As Investing Activities | €0 | €0 |
| Effect of Exchange Rate Changes On Cash and Cash Equivalents | €0 | €0 |
| Equity and Liabilities | €1.95B | €1.84B |
| Fee and Commission Expense | €2.5M | €2.5M |
| Fee and Commission Income | €57.4M | €52.0M |
| Fee and Commission Income Expense | €54.9M | €49.4M |
| Financial Assets At Amortised Cost | €1.34B | €1.31B |
| Financial Assets At Fair Value Through Profit Or Loss | €35.5M | €27.9M |
| Financial Assets At Fair Value Through Profit Or Loss Classified As Held For Trading | €9.3M | €6.8M |
| Financial Assets At Fair Value Through Profit Or Loss Mandatorily Measured At Fair Value | €26.1M | €21.0M |
| Financial Assets Measured At Fair Value Through Other Comprehensive Income | €345.9M | €341.8M |
| Financial Liabilities At Amortised Cost | €1.65B | €1.55B |
| Financial Liabilities At Fair Value Through Profit Or Loss Classified As Held For Trading | €2.1M | €40.0K |
| Gain Loss Arising From Derecognition of Financial Assets Measured At Amortised Cost | €155.0K | €278.0K |
| Gains Losses On Financial Assets At Fair Value Through Profit Or Loss Mandatorily Measured At Fair Value | €17.0K | -€399.0K |
| Impairment Loss Impairment Gain and Reversal of Impairment Loss Determined In Accordance With IFRS9 | €1.1M | €5.2M |
| Increase Decrease Through Appropriation of Retained Earnings | €0 | €0 |
| Increase Decrease Through Changes In Ownership Interests In Subsidiaries That Do Not Result In Loss of Control | €0 | €0 |
| Increase Decrease Through Sharebased Payment Transactions | €0 | €0 |
| Increase Decrease Through Transfers and Other Changes Equity | -€8.8M | -€3.1M |
| Interest Expense | €3.5M | €2.3M |
| Interest Revenue Calculated Using Effective Interest Method | €9.9M | €14.9M |
| Interest Revenue Expense | €10.2M | €16.2M |
| Investment Accounted For Using Equity Method | €10.4M | €10.7M |
| Issue of Equity | €0 | €0 |
| Issued Capital | €72.6M | €72.6M |
| Loans and Advances To Banks | €54.4M | €52.6M |
| Loans and Advances To Customers | €1.29B | €1.25B |
| Miscellaneous Other Provisions | €69.0K | €67.0K |
| Other Adjustments To Reconcile Profit Loss | -€1.4M | €8.3M |
| Other Assets | €38.4M | €23.3M |
| Other Comprehensive Income | €2.7M | €2.1M |
| Other Comprehensive Income Net of Tax Gains Losses From Investments In Equity Instruments | €3.4M | €906.0K |
| Other Comprehensive Income Net of Tax Gains Losses On Remeasurements of Defined Benefit Plans | €15.0K | €110.0K |
| Other Liabilities | €23.4M | €18.8M |
| Other Operating Income Expense | €5.4M | €5.0M |
| Other Provisions | €124.0K | €313.0K |
| Proceeds From Sales of Intangible Assets Classified As Investing Activities | €0 | €0 |
| Proceeds From Sales of Investments Accounted For Using Equity Method | €0 | €333.0K |
| Proceeds From Sales of Property Plant and Equipment Classified As Investing Activities | €1.0K | €0 |
| Profit Loss From Continuing Operations | €8.6M | €7.8M |
| Purchase of Interests In Investments Accounted For Using Equity Method | €0 | €0 |
| Purchase of Treasury Shares | €0 | €0 |
| Recognised Liabilities Defined Benefit Plan | €5.8M | €5.6M |
| Revaluation Surplus | €10.3M | €7.6M |
| Revenue From Dividends | €722.0K | €1.8M |
| Revenue From Interest | €13.7M | €18.4M |
| Share of Other Comprehensive Income of Associates and Joint Ventures Accounted For Using Equity Method That Will Not Be Reclassified To Profit Or Loss Net of Tax | -€34.0K | €20.0K |
| Share of Profit Loss of Associates and Joint Ventures Accounted For Using Equity Method | -€242.0K | -€199.0K |
| Trading Income Expense | €1.5M | -€253.0K |
| Treasury Shares | €14.1M | €14.1M |
Methodology
Every line item above is a fact tagged in "BANCA FINNAT EURAMERICA S.P.A." E, IN FORMA ABBREVIATA "BANCA FINNAT S.P.A." O ANCHE "BANCA EURAMERICA S.P.A."'s annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (EUR), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.